Assignee
RELMADA THERAPEUTICS INC
US·2 granted patents·3 pending applications·0 citations·filing 2016–2020
Top patents by PatentIndex Score
5 records- 0152US10624887B2Compositions of (-)-17-(cyclobutylmethyl)morphinan-3,14,-diolRELMADA THERAPEUTICS INC·Filed 2016·Granted Apr 21, 2020·0 cites·16 claims
- 0246US2022105085A1Abrasion-resistant opioid formulations which resist abuse and include a sequestered opioid antagonistRELMADA THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 0341US9855226B2d-methadone for the treatment of psychiatric symptomsRELMADA THERAPEUTICS INC·Filed 2016·Granted Jan 2, 2018·0 cites·20 claims
- 0440US2017326134A1Abrasion-Resistant Opioid FormulationsRELMADA THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 0540US2016176890A1Oral Pharmaceutical Compositions of Buprenorphine and Another Opioid Receptor AgonistRELMADA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →